The Psychological Risks Associated With the Non-medical Switch From Biologics to Biosimilars

by Davide Mazzoni, Claudia Vener, Ketti Mazzocco, Ketti Mazzocco, Dario Monzani, Dario Monzani, Gabriella Pravettoni, Gabriella Pravettoni
Published 2021-01-01

Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates.

by Lorenza Pugni, Carlo Pietrasanta, Silvano Milani, Claudia Vener, Andrea Ronchi, Mariella Falbo, Milena Arghittu, Fabio Mosca
Published 2015-01-01

Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial

by Carlo Pietrasanta, Andrea Ronchi, Claudia Vener, Chiara Poggi, Claudia Ballerini, Lea Testa, Rosaria Maria Colombo, Elena Spada, Carlo Dani, Fabio Mosca, Lorenza Pugni
Published 2021-05-01

Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project

by Matteo Franchi, Claudia Vener, Donatella Garau, Ursula Kirchmayer, Mirko Di Martino, Marilena Romero, Ilenia De Carlo, Salvatore Scondotto, Chiara Stival, Matteo Giovanni Della Porta, Francesco Passamonti, Giovanni Corrao
Published 2021-02-01